Drum Hill Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Drum Hill Capital, LLC
- $80.5 Billion
- Q4 2024
A detailed history of Drum Hill Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Drum Hill Capital, LLC holds 300 shares of REGN stock, worth $200,055. This represents 0.27% of its overall portfolio holdings.
Number of Shares
300Holding current value
$200,055% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,499Shares Held
82.9MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.22 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.63 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$4.99 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.27 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.87 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $71.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...